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Background: Surveillance of healthcare-associated infections (HAI) is a valuable measure to decrease infection rates.
Across Europe, inter-country comparisons of HAI rates seem limited because some countries use US definitions
from the US Centers for Disease Control and Prevention (CDC/NHSN) while other countries use European
definitions from the Hospitals in Europe Link for Infection Control through Surveillance (HELICS/IPSE) project. In this
study, we analyzed the concordance between US and European definitions of HAI.
Methods: An international working group of experts from seven European countries was set up to identify
differences between US and European definitions and then conduct surveillance using both sets of definitions
during a three-month period (March 1st -May 31st, 2010). Concordance between case definitions was estimated
with Cohen’s kappa statistic (κ).
Results: Differences in HAI definitions were found for bloodstream infection (BSI), pneumonia (PN), urinary tract
infection (UTI) and the two key terms “intensive care unit (ICU)-acquired infection” and “mechanical ventilation”.
Concordance was analyzed for these definitions and key terms with the exception of UTI. Surveillance was
performed in 47 ICUs and 6,506 patients were assessed. One hundred and eighty PN and 123 BSI cases were
identified. When all PN cases were considered, concordance for PN was κ = 0.99 [CI 95%: 0.98-1.00]. When PN cases
were divided into subgroups, concordance was κ = 0.90 (CI 95%: 0.86-0.94) for clinically defined PN and κ = 0.72
(CI 95%: 0.63-0.82) for microbiologically defined PN. Concordance for BSI was κ = 0.73 [CI 95%: 0.66-0.80]. However,
BSI cases secondary to another infection site (42% of all BSI cases) are excluded when using US definitions and
concordance for BSI was κ = 1.00 when only primary BSI cases, i.e. Europe-defined BSI with ”catheter” or “unknown”
origin and US-defined laboratory-confirmed BSI (LCBI), were considered.
Conclusions: Our study showed an excellent concordance between US and European definitions of PN and
primary BSI. PN and primary BSI rates of countries using either US or European definitions can be compared if the
points highlighted in this study are taken into account.
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Implementation of surveillance of healthcare-associated
infections (HAI) has been shown to result in decreasing
HAI rates and contributes to the prevention of HAI [1–3].
Feedback of data on HAI rates to clinical staff has been
shown to be a key factor reducing these rates [4–6].* Correspondence: sonja.hansen@charite.de
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ence data seems to be particularly successful. In the 1970s,
the US Centers for Disease Control and Prevention (CDC)
created the National Nosocomial Infection Surveillance
System (NNIS) and published uniform surveillance defini-
tions for nosocomial infections [7–9]. These definitions
have been updated gradually for surgical site infection
(SSI) [10], for ventilator-associated pneumonia (VAP) [11],
primary bloodstream infection (BSI) [12] and in 2010
for urinary tract infection (UTI) [13]. Key terms such
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system is now integrated as part of the National
Healthcare Safety Network (NHSN) [12].
In the 1980s and 1990s, many European countries
performed national prevalence studies of HAI and estab-
lished national surveillance systems using CDC defini-
tions or a modified version of these definitions [15],
while other countries developed their own surveillance
definitions that better reflected European diagnostic
practices. The first harmonization of national surveillance
activities in Europe was performed by the Hospitals in
Europe Link for Infection Control through Surveillance
(HELICS) project, which was funded by the European
Commission in the context of Decision 2119/98/EC of
the European Parliament and of the Council on commu-
nicable disease surveillance and control in EU Member
States [16].
The HELICS project (2000–2004) developed case
definitions for surgical site infection (SSI), pneumonia
(PN), bloodstream infection (BSI), catheter-related infec-
tion (CRI) and urinary tract infection (UTI) and recom-
mended their use in EU Member States [17,18]. The
work of HELICS was continued as a component of the
European Commission-funded Improving Patient Safety
in Europe (IPSE) network (2005–2008). The IPSE
network aimed at contributing to European surveillance
of HAI by describing HAI epidemiology, improving the
understanding of inter-country variation of HAI rates
and facilitating quality-of-care improvements in a multi-
centre setting. In July 2008, the IPSE network was trans-
ferred to the European Centre for Disease Prevention
and Control (ECDC) [19,20]. Since this date, HAI
surveillance activities in Europe are coordinated by
ECDC and the network was re-named the Healthcare-
Associated Infections surveillance Network (HAI-Net).
HAI-Net adopted the European (HELICS/IPSE) defini-
tions for its HAI surveillance modules and for the
ECDC point prevalence survey of HAI in European
acute care hospitals. Comparisons of HAI rates between
countries are essential to raising awareness about HAI
and their prevention and control, but require a stan-
dardized methodology, including uniform definitions.
Because they were implemented independently, na-
tional HAI surveillance systems in European countries
decided to use either the US (CDC/NHSN) definitions
[12–14] or the European (HELICS/IPSE) definitions
[17,18] and questions have been raised about whether
comparisons of HAI rates between national networks
were indeed appropriate. While adoption of the European
definitions is mandatory for newly implemented na-
tional HAI surveillance systems, changing definitions
could interrupt continuity of reference data and require
reorganization for an existing national surveillance
system.The present study was conducted to assess the concord-
ance between US (CDC/NHSN) definitions and European
(HELICS/IPSE) definitions of HAI for inter-country com-
parison of HAI rates. The study was initiated and sponsored
by ECDC through a specific service contract (ECD.1781)
with the Institute for Hygiene and Environmental Medicine,
Charité – University Medicine Berlin, Germany.
Methods
Setting
The study was conducted in seven European countries
(Austria, Belgium, France, Germany, Hungary, Italy and
Spain) with existing networks for HAI surveillance.
Network leaders and a senior expert from ECDC (CS)
represented the international study working group respon-
sible for the development and implementation of the study.
Three meetings at the Institute of Hygiene, Charité –
University Medicine, Berlin, were held to agree on the
methodology, data collection and analysis.
A one-month study pre-test was performed in two
countries to evaluate the feasibility of the study.
Surveillance
HAI surveillance was performed in intensive care
units (ICUs) in all participating countries between
March 1st and May 31st, 2010. Network leaders delivered
study documents and trained the local surveillance
personnel for both types of definitions by using standar-
dized case studies. No validation phase was included
in the study.
All patients aged one year or above that presented with
symptoms for selected HAI were included in surveillance
according to both types of definitions. The HAI did not
necessarily need to be acquired in the participating ICU,
and patients coming from another ward of the same
hospital with symptoms of infection were also surveyed
upon ICU admission.
Local surveillance personnel collected data by using both
types of definitions simultaneously. A study case was
defined as a patient with a HAI according to either type of
definition. In addition to the definitions’ criteria, the follow-
ing data were obtained for further analysis: date of birth,
date of admission to the ICU and to the hospital, date of
onset of HAI, underlying cardiac or pulmonary diseases,
and immunosuppression status. In addition, surveillance
personnel assessed whether the infection was ICU-
acquired, according to both sets of criteria. Association with
a central line or with mechanical ventilation was also
included according to the US and the European definitions.
BSI cases that did not fulfill the criteria of US definitions
for laboratory-confirmed bloodstream infection (LCBI)
because signs and symptoms were related to an infection at
another site, were recorded as “secondary BSI missed by
US definitions”.
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Because the question remains open as to which set of
definitions represents the gold standard, we could only
assess, for each type of infection, the concordance
(agreement) between the two types of definitions. To
estimate the concordance between two case definitions,
Cohen’s kappa ( κ) statistic [21,22] was chosen.
For sample size calculation, an incidence of HAI (BSI
and PN) of 1–5 per 100 patients was assumed and a
kappa value of 0.75-0.90 was anticipated according to
previous HAI concordance studies [23–26]. Based on a
kappa value of 0.75 and on an expected HAI incidence of




Both sets of definitions of HAI were reviewed by the
working group. The group identified differences for the
definitions of BSI, PN and UTI (Table 1).
BSI definitions varied since CDC/NHSN does not
accept a positive blood culture with a microorganismTable 1 Differences in HAI definitions (CDC/NHSN vs. HELICS/
Type of HAI or key term CDC/NHSN definitions
Bloodstream infection (BSI) /
Laboratory-confirmed
bloodstream Infection (LCBI)
•LCBI (Positive blood culture with recognize
or 2 blood cultures with skin contaminant
symptoms. Organism cultured from blood
to an infection at another site)
•CSEP (Clinical sepsis in patients≤ 1 year)
Catheter-related infection (CRI) -*
Pneumonia (PNU/PN) • PNU1 (Clinically defined pneumonia)
• PNU2 (Pneumonia with specific laboratory
• PNU3 (Pneumonia in immunocompromis
Urinary tract infection (UTI) • SUTI (Symptomatic UTI) †/‡
• ASB (Asymptomatic bacteriuria) † /
•ABUTI (Asymptomatic bacteremic UTI) ‡
• OUTI (Other infections of the urinary tract
ICU-acquired HAI • No evidence that the infection was prese
incubating at the time of admission to the
Ventilator-associated • A device to assist or control respiration co
through a tracheostomy or by endotrachea
was present within the 48-hour period bef
onset of infection, inclusive of the weaning
*, not applicable.
†, until December 2008.
‡, since January 2009.related to an infection at another site. PN definitions
were different concerning the microbiological diagnostic
criteria: HELICS/IPSE includes more detailed categories
according to the sampling procedure and the microbiology
technique whereas CDC/NHSN definitions include add-
itional age-dependent criteria and a specific subcategory
for immunocompromised patients (PNU3). UTI definitions
were identical until the end of 2009. Differences appeared
when CDC/NHSN modified its UTI definitions to include
the new subcategory “asymptomatic bacteremic UTI” in
January 2010.
Definitions of the key term “ICU-acquired infection”
varied because HELICS/IPSE defines it as an infection
occurring later than 48 hours after admission to an ICU,
whereas CDC/NHSN requires that there is no evidence
that the infection was present or incubating at the time
of admission to the ICU, without time restriction [12].
There were also differences for the key term “mechanical
ventilation”, which are described in Table 1.
The working group agreed to analyze concordance for
the definitions of BSI and PN, and for the key terms






(Positive blood culture with recognized pathogen or
2 blood culture with skin contaminant incl. clinical
symptoms. Origin: “Catheter” (C), “Secondary to
another site” (S) or “Unknown” (U))
•CRI 1 (Local central venous catheter
(CVC)-related infection)
•CRI 2 (General CVC-related infection)
• CRI 3 (CVC-related BSI)
• CCO (Catheter colonisation)
• PN 1 (Protected sample + quantitative culture)
findings) • PN 2 (Non-protected sample + quantitative culture)
ed patients) • PN 3 (Alternative microbiological criteria)
• PN 4 (Sputum bacteriology or non-quantitative
endotracheal aspirate (ETA))
• PN 5 (No microbiological criterion (only clinical criteria))
• UTI-A (Symptomatic, microbiologically confirmed)
• UTI-B (Symptomatic , not microbiologically confirmed)
) †/‡ • UTI-C (Asymptomatic bacteriuria)
nt or
ICU






• An invasive respiratory device was present
(even intermittently) in the 48 hours preceding the
onset of infection
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differences because of recent modifications, UTI definitions
were excluded from the study.
Participating ICUs
Surveillance was performed in 47 ICUs in 28 hospitals
across 7 EU countries. The majority of participating
ICUs were mixed ICUs, followed by medical and surgical
ICUs. Three countries also surveyed paediatric patients
in 9% of their participating ICUs. The characteristics of
participating ICUs are presented in Table 2.
Agreement of definitions
For the study, 6,506 patients were assessed. The incidence
of PN and of BSI were 2.8 and 1.9 per 100 patients,
respectively. Overall, 180 PN and 123 BSI cases were
identified by either the US definitions or the European
definitions (Figures 1 and 2). Of all 180 PN cases, 178 were
identified with the European definitions and 179 with the
US definitions. Two PN cases were only identified with the
US definitions due to age-dependent criteria that are not
included in the European definitions. The third discordant
case was a patient with microbiological findings that
fulfilled a criterion for “PN 2” of the European definitions,
but without sufficient criteria for PN according to the US
definitions. These findings led to a kappa value of 0.99
for PN. Kappa values were lower when PN cases were
subdivided into clinically defined PN (κ = 0.90) and
microbiologically defined PN (κ = 0.72).
Since this subdivision did not take into account
US-defined PNU3 cases (PN in immunocompromised
patients), those cases were reclassified into US-defined
PNU1 and PNU2. A repeated analysis of agreement within
the new clinically and microbiologically defined PN groups
resulted in equal agreement for clinically defined PN
(κ = 0.90) and higher agreement for microbiologically










Austria 7 / 1 3 3 0 0 1
Belgium 5 / 4 3 1 1 0 0
France 4 / 4 2 0 2 0 0
Germany 5 / 1 2 0 0 1 2
Hungary 15 / 10 7 1 2 2 3
Italy 7 / 4 2 1 2 0 2
Spain 4 / 4 3 0 0 0 1
All 47 / 28 22 6 7 3 9
* An ICU was defined as belonging to a specialty if ≥ 80% of patients in this ICU be
† Other: Neurosurgery, Paediatrics, Transplant surgery, Burn, Neurology.Agreement of definitions for BSI showed a kappa value
of 0.73. All 123 BSI cases were diagnosed by the European
criteria. Forty-two percent of the BSI cases were missed
when US definitions were used (Figure 2) because they
were secondary to an infection at another site. In the
remaining 72 cases, the BSI origin was either a catheter
(central venous, peripheral or arterial) (30%) or unknown
(29%). BSI concordance was perfect (κ = 1.00) when only
primary BSI cases, i.e. Europe-defined BSI with either
“catheter” or “unknown” origin and US-defined “LCBI”,
were analyzed.
For 245 (81%) of all cases the concordance of the key
term “ICU-acquired” was analyzed. A few more HAI
were classified as “ICU-acquired” according to the US
definitions than to the European definitions (245 vs.
240); agreement was equal for ICU-acquired PN and for
ICU-acquired BSI (κ = 0.94) (Table 3).
Discussion
HAI surveillance methods vary across Europe. Some
countries use European definitions while other coun-
tries use US definitions. As a contribution to further
harmonization of Europe-wide surveillance of HAI, this
study assessed the concordance between US and European
definitions of BSI and of PN, two major types of HAI that
are partly preventable [27] and are under surveillance in
most European countries. The recommendations of Landis
and Koch for evaluating the strength of an agreement were
used [28]. Overall, an “almost perfect” agreement was found
for PN (κ = 0.99). This was different when PN cases were
subdivided into clinically and microbiologically defined PN.
More PN cases were classified as microbiologically-defined
PN following the European definitions than the US defini-
tions. This was still the case when Europe-defined PN2
cases which are based on the criteria “non-protective sam-
ple and quantitative culture” were considered as clinically
defined PN. This difference was no longer evident when allMedian number of
beds per hospital
Median number
of beds per ICU
Median number






2,137 8 8 132
854 18 18 1,318
504 11 11 323
3,200 11 11 689
1,163 10 10 2,311
474 8 8 1,031
600 19 16 702
854 11 11 6,506
longed to this specialty.
Figure 1 Pneumonia cases diagnosed according to both
definition types.
Figure 2 BSI cases diagnosed according to both definition
types, inclusive the mapping of conform criteria (+).
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cases were reclassified into the US-defined categories
PNU1 or PNU2. Since all 26 PNU3 cases could be classified
as either PNU1 cases (n = 2) or PNU2 cases (n = 24), the
results of this study suggest that the PNU3 subcategory
may not be essential when performing surveillance of PN
in immunocompromised patients.
As expected, concordance of BSI definitions was only
“substantial” according to Landis and Koch [28]. Since
one major criterion of US definitions, i.e. signs and
symptoms of BSI must not be related to an infection at
another site, is not included in the European definitions,
51 (42%) BSI cases were not identified with the US
definition. With the European BSI definition, which
includes the specification of the origin of the BSI, these51 BSI cases were reported as “secondary to another
infection site”.
European definitions provide two more categories, i.e.
“catheter” and “unknown”, for origin of BSI [18]. The
origin “catheter” was reported in 37 (30%) BSI cases and
the origin “unknown” was reported in 35 (29%) BSI
cases, which correspond to the “primary BSI” of the US
definitions. All 72 of these BSI cases were also defined
as LCBI cases with the US definitions. Thus for a potential
comparison, US-defined LCBI cases should only be related
to Europe-defined BSI cases with either “catheter” or
“unknown” origin.
Definitions of the key term “ICU-acquired HAI” varied
between the U.S. and Europe. According to European
definitions 97% of HAI cases were defined as ICU-
acquired (i.e. HAI occurring later than 48 hours after
admission in the ICU). By contrast, according to the US
definitions, all HAI cases were defined as ICU-acquired
(i.e., no evidence that the infection was present or incu-
bating at the time of admission to the ICU). Since US
Table 3 Concordance of HAI definitions, determined by Cohen’s kappa statistic
Type of HAI
or key term
Included cases based on: Incidence of
HAI (no. cases
per 100 patients)
























Pneumonia PNU1 + PNU2 + PNU3 PN1 + PN2 + PN3 +
PN4 + PN5
2.8 180 177 1 2 6,326 0.99 [0.98 ; 1.00]
Clinically defined
pneumonia
PNU1 PN2 + PN4 + PN5 2.0 127 102 23 2 6,379 0.89 [0.85 ; 0.93]
PNU1 PN4 + PN5 1.8 119 92 15 12 6,387 0.87 [0.82 ; 0.92]
PNU1* PN2 + PN4 + PN5 2.0 127 104 21 2 6,379 0.90 [0.86 ; 0.94]
PNU1* PN4 + PN5 1.8 119 94 13 12 6,387 0.88 [0.83 ; 0.93]
Microbiologically
defined pneumonia
PNU2 PN1 + PN3 1.0 65 37 16 12 6,441 0.72 [0.63 ; 0.82]
PNU2 PN1 + PN2 + PN3 1.2 78 42 29 7 6,428 0.70 [0.60 ; 0.79]
PNU2† PN1 + PN3 1.1 73 53 0 20 6,433 0.84 [0.77 ; 0.91]




or in incubation at
admission
Pneumonia occurring
>48 h after admission






















1.9 123 72 51 0 6,383 0.73 [0.66 ; 0.80]
Primary BSI Microorganism is not
related to infection
at another site
Origin of BSI is
“catheter” or
“unknown”
1.1 72 72 0 0 51 1.00
ICU-acquired BSI BSI not present or
in incubation at
admission
BSI occurring >48 h
after admission
1.5 98 96 0 2 22 0.94 [0.87 ; 1.00]
*Including PNU3 cases (pneumonia in the immunocompromised patient) qualified as PNU1 after redistribution of PNU3 cases into PNU1 or PNU2.
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to the ICU and onset of symptoms, it is easy to explain
why a few more HAI were recorded as ICU-acquired
according to the US definitions. Nevertheless, agreement
for the key term “ICU-acquired HAI” was still “almost
perfect” according to Landis and Koch [28].
A strength of our study is that it was performed in
seven European countries with different diagnostic
methods and habits reflecting the variety of diagnostic
practices in Europe. A limitation of the study is that the
time of admission to the ICU and the time of onset of
the HAI were recorded less precisely (in “days” instead
of “hours”) than in the original definition because the
findings of the study pre-test revealed major difficulties
in collecting time of onset data in “hours”. As a conse-
quence, all HAI occurring on or after the third day of
ICU stay (rather than after 48 hours according to the
European definitions), were defined as ICU-acquired. A
further limitation was that specific patient groups, such
as paediatric and immunocompromised patients, were
likely to be underrepresented in the study.
In conclusion, countries using either US or European
definitions for HAI surveillance can compare PN and
primary BSI rates as long as the following points are
taken into account. First, data should of course be valid
and be collected following the original US and European
definitions since country-specific modification of defini-
tions may result in additional differences [29]. Second,
PN data should always be compared in total, but not as
subcategories of clinically defined and microbiologically
defined PN. Third, for BSI the source should always be
reported since all BSI cases with the origin “secondary to
another site” according to European definitions should
be excluded when making comparisons with US-defined
BSI. Fourth, only Europe-defined BSI cases with either
“catheter” or “unknown” origin should be compared to
US-defined LCBI cases. Fifth, there are differences
between US and European surveillance protocols, other
than just case definitions of HAI, and these differences
should be taken into account before performing compari-
son of HAI rates. Finally, comparisons are valid as long
as US and European definitions do not change. Indeed,
changing US definitions for PN to ventilator-associated
complications under the influence of public reporting
[30,31] would certainly affect the current good concordance
between US and European definitions of PN.
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